GlassScriptPhysician profile
Jacqueline Cosme
NPI 1811096506
$1,507.00
in general payments reported to CMS, 2019-2025
18 companies · $75.85 in 2025
The $75.85 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $183 · 2021: $297 · 2022: $196 · 2023: $153 · 2024: $152 · 2025: $75.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $733.06 | 2019-2025 | Bexsero, Pediarix, Nucala |
| Kaleo, INC. | $171.41 | 2019-2023 | Auvi-Q |
| Genentech USA, INC. | $95.41 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $86.05 | 2019-2022 | |
| Cranial Technologies, INC | $48.97 | 2021-2023 | Doc Band |
| Antares Pharma, INC. | $46.33 | 2019 | |
| Pfizer INC. | $40.17 | 2019-2020 | |
| Gilead Sciences, INC. | $40.13 | 2021 | |
| Seqirus USA INC | $36.91 | 2022-2024 | Flucelvax |
| Phadia US INC. | $35.13 | 2024-2025 | Immunocap |
| Abbott Laboratories | $27.63 | 2025 | Id Now Instrument |
| Astrazeneca Pharmaceuticals LP | $24.78 | 2021 | |
| Sanofi Pasteur INC. | $22.15 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.46 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.76 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $19.60 | 2021 | |
| Ironshore Pharmaceuticals INC. | $19.43 | 2020 | |
| Hologic Sales and Service, LLC | $17.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Cosme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.